Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52


Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.

Goldstein DS, Holmes C, Sullivan P, Jinsmaa Y, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2016 Oct;31:79-86. doi: 10.1016/j.parkreldis.2016.07.009.


Catecholamines and Neurodegeneration in Parkinson's Disease-From Diagnostic Marker to Aggregations of α-Synuclein.

Sawada H, Oeda T, Yamamoto K.

Diagnostics (Basel). 2013 Mar 25;3(2):210-21. doi: 10.3390/diagnostics3020210. Review.


Evaluation of Cardiac Autonomic Functions in Older Parkinson's Disease Patients: a Cross-Sectional Study.

Yalcin A, Atmis V, Cengiz OK, Cinar E, Aras S, Varli M, Atli T.

Aging Dis. 2016 Jan 2;7(1):28-35. doi: 10.14336/AD.2015.0819.


Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection.

Mukherjee UA, Ong SB, Ong SG, Hausenloy DJ.

Pharmacol Ther. 2015 Dec;156:34-43. doi: 10.1016/j.pharmthera.2015.10.005. Review.


Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.

Goldstein DS, Holmes C, Sullivan P, Mash DC, Sidransky E, Stefani A, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2015 Sep;21(9):1013-22. doi: 10.1016/j.parkreldis.2015.07.009.


(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.

Chung EJ, Kim SJ.

J Mov Disord. 2015 May;8(2):55-66. doi: 10.14802/jmd.15015. Review.


Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.

Joers V, Dilley K, Rahman S, Jones C, Shultz J, Simmons H, Emborg ME.

PLoS One. 2014 Aug 18;9(8):e104850. doi: 10.1371/journal.pone.0104850.


Morbidity in early Parkinson's disease and prior to diagnosis.

Frandsen R, Kjellberg J, Ibsen R, Jennum P.

Brain Behav. 2014 May;4(3):446-52. doi: 10.1002/brb3.228.


Positron emission tomography in the differential diagnosis of parkinsonism.

Rinne JO.

J Mov Disord. 2009 Oct;2(2):53-7. doi: 10.14802/jmd.09015. Review.


A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.

Goldstein DS, Sullivan P, Holmes C, Miller GW, Sharabi Y, Kopin IJ.

J Neurochem. 2014 Oct;131(2):219-28. doi: 10.1111/jnc.12766.


Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Joers V, Emborg ME.

Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):125-59. Review.


Dysautonomia in Parkinson disease.

Goldstein DS.

Compr Physiol. 2014 Apr;4(2):805-26. doi: 10.1002/cphy.c130026. Review.


Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.

Dorszewska J, Prendecki M, Oczkowska A, Rozycka A, Lianeri M, Kozubski W.

Curr Genomics. 2013 Dec;14(8):518-33. doi: 10.2174/1389202914666131210210241.


Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Oczkowska A, Kozubski W, Lianeri M, Dorszewska J.

Curr Genomics. 2013 Dec;14(8):502-17. doi: 10.2174/1389202914666131210205839.


Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Goldstein DS.

Compr Physiol. 2013 Oct;3(4):1569-610. doi: 10.1002/cphy.c130006. Review.


Sympathetic neuroimaging.

Goldstein DS.

Handb Clin Neurol. 2013;117:365-70. doi: 10.1016/B978-0-444-53491-0.00029-8. Review.


Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.

Stuebner E, Vichayanrat E, Low DA, Mathias CJ, Isenmann S, Haensch CA.

Front Neurol. 2013 May 15;4:49. doi: 10.3389/fneur.2013.00049.


Parkinson's disease.

Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA.

Subcell Biochem. 2012;65:389-455. doi: 10.1007/978-94-007-5416-4_16. Review.


Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.

Wong KK, Raffel DM, Koeppe RA, Frey KA, Bohnen NI, Gilman S.

Radiology. 2012 Oct;265(1):240-7.

Items per page

Supplemental Content

Support Center